Skip to main content
Anish Bhatnagar, MD, Pulmonology, Newark, NJ

Anish Bhatnagar MD

Critical Care Medicine


Pulmonary and Critical Care Medicine Fellow

Join to view full profile
  • 90 Bergen St# 4500Newark, NJ 07103

  • Phone+1 973-972-2500

Dr. Bhatnagar is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2022 - 2025
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterChief Residency, Internal Medicine, 2021 - 2022
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2018 - 2021
  • University of Utah School of Medicine
    University of Utah School of MedicineClass of 2018

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2018 - 2027
  • NJ State Medical License
    NJ State Medical License 2025 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Press Mentions

  • Vykat XR Approved as First Treatment for Excessive Appetite in Prader-Willi Syndrome
    Vykat XR Approved as First Treatment for Excessive Appetite in Prader-Willi SyndromeApril 15th, 2025
  • First Drug Approved for Hyperphagia in Prader-Willi Syndrome
    First Drug Approved for Hyperphagia in Prader-Willi SyndromeMarch 28th, 2025
  • Diazoxide Choline Gets Priority Review for Prader-Willi Syndrome
    Diazoxide Choline Gets Priority Review for Prader-Willi SyndromeAugust 27th, 2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: